HMA/VEN treatment modifications and associated outcomes in IDH-mutant AML.
Chin KK, Derkach A, Famulare C, Gupta GK, Borge PD, Geyer MB, Goldberg AD, Haque T, Park JH, Roeker LE, Tallman MS, Stahl M, Stein EM.
Chin KK, et al. Among authors: goldberg ad.
Leuk Lymphoma. 2024 Oct 14:1-9. doi: 10.1080/10428194.2024.2411436. Online ahead of print.
Leuk Lymphoma. 2024.
PMID: 39397429